A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.


Updates from The Motley Fool

Latest updates on MABVAX THERAPEUTICS from Fool.com.
Is Telik Insane?

Shares of Telik fall after the FDA puts a halt to trials with its lead drug.

Three Strikes for Telik

There's not much in the pipeline at this small biotech company.

The 5-Sigma Report

A look at the stocks that saw serious volatility last week.

Telik Falls Short

Shares of another biopharma fall after disappointing clinical trial results.



Stock Performance

View Interactive MBVX Charts
Sponsored by

Key Data Points

Primary metrics and data points about MABVAX THERAPEUTICS.
Current Price: $2.45
Prev Close: $2.52
Open: $2.45
Bid: $2.40
Ask: $3.69
Day's Range: $2.45 - $2.48
52wk Range: $2.35 - $6.40
Volume: 9,120
Avg Vol 88,311
Market Cap: $15M
P/E (ttm): -0.69
EPS (ttm): ($3.64)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about MABVAX THERAPEUTICS.
CAPS Rating 1 out of 5
 
57 Outperform
51 Underperform
CAPS All Stars
 
7 Outperform
25 Underperform

How do you think MABVAX THERAPEUTICS will perform against the market?



You pick for MABVAX THERAPEUTICS is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for MABVAX THERAPEUTICS.

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers